- Home
- MREO vs ERC Comparison
MREO vs ERC Comparison
Compare MREO & ERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- ERC
- Stock Information
- Founded
- MREO 2015
- ERC 2003
- Country
- MREO United Kingdom
- ERC United States
- Employees
- MREO N/A
- ERC N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- ERC Finance/Investors Services
- Sector
- MREO Health Care
- ERC Finance
- Exchange
- MREO Nasdaq
- ERC Nasdaq
- Market Cap
- MREO 311.8M
- ERC 265.7M
- IPO Year
- MREO N/A
- ERC N/A
- Fundamental
- Price
- MREO $2.16
- ERC $9.34
- Analyst Decision
- MREO Strong Buy
- ERC
- Analyst Count
- MREO 5
- ERC 0
- Target Price
- MREO $7.40
- ERC N/A
- AVG Volume (30 Days)
- MREO 1.4M
- ERC 64.4K
- Earning Date
- MREO 11-11-2025
- ERC 01-01-0001
- Dividend Yield
- MREO N/A
- ERC 8.37%
- EPS Growth
- MREO N/A
- ERC N/A
- EPS
- MREO N/A
- ERC 0.72
- Revenue
- MREO $500,000.00
- ERC N/A
- Revenue This Year
- MREO N/A
- ERC N/A
- Revenue Next Year
- MREO $72.16
- ERC N/A
- P/E Ratio
- MREO N/A
- ERC $12.92
- Revenue Growth
- MREO N/A
- ERC N/A
- 52 Week Low
- MREO $1.47
- ERC $8.51
- 52 Week High
- MREO $4.72
- ERC $9.74
- Technical
- Relative Strength Index (RSI)
- MREO 61.75
- ERC 39.50
- Support Level
- MREO $1.94
- ERC $9.27
- Resistance Level
- MREO $2.28
- ERC $9.57
- Average True Range (ATR)
- MREO 0.12
- ERC 0.10
- MACD
- MREO 0.01
- ERC -0.04
- Stochastic Oscillator
- MREO 65.53
- ERC 13.86
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About ERC Allspring Multi-Sector Income Fund
Allspring Multi-Sector Income Fund is a closed-end investment management company. The company's core business is to secure a high level of income for its investors consistent with limiting its overall exposure to domestic interest rate risk. It invests in U.S. dollar-denominated below investment-grade bonds, debentures, and other income obligations, including loans and preferred stocks, developed and emerging market debt securities, including obligations of foreign governments or governmental entities, foreign corporations, or supranational agencies denominated in various currencies, asset backed securities and investment grade corporate bonds.